Trask Adam Roland

Position in NVS — Novartis AG

CIK 2109050 GRAND RAPIDS, MI

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,550

New position

Shares Held

200

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Trask Adam Roland holds $12,393,470 across 5 Drug Manufacturers - General names. NVS ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	8,308	$7,641,449
2	ABBV	AbbVie Inc.	13,003	$2,828,022
3	JNJ	Johnson & Johnson	7,716	$1,886,099
4	NVS	Novartis AG This page	200	$30,550
5	NVO	Novo Nordisk A S	200	$7,350

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,550	200	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.